Contract Development Services

Catalent to Supply BeiGene’s Brukinsa

November 25, 2019

The companies announced a commercial supply agreement following FDA’s accelerated approval.

Thermo Fisher Scientific Expands Capabilities

November 22, 2019

New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.

Particle Sciences Rebrands as Lubrizol Life Science Health

November 22, 2019

Lubrizol Life Science Health adopts new name and opens commercial manufacturing facility.

Lonza, Genmab Extend Drug Development Partnership

October 15, 2019

Lonza, through its Ibex Solutions, will now cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline.

Stability Testing for Small-Molecule Clinical Trial Materials

October 02, 2019

Limited guidance and numerous challenges create confusion about the scope and timing of stability testing for drugs in development.

Uncovering Hidden Risks in Solid-State API Properties

October 01, 2019

An understanding-during early development-of the solid form landscape of an API can enhance product quality and manufacturing processes.

Market Dynamics Drive the Agenda for CPhI Worldwide

October 01, 2019

New therapies, new technologies, global supply chain challenges, and political pressures draw pharma professionals to major industry event.

Taiwanese CDMO Gains FDA Approval for Zhunan Facility

September 13, 2019

Bora Pharmaceuticals has announced it has achieved success in the latest FDA general inspection of its Zhunan facility with zero 483 observations.

Pharma Contract Market Update

August 02, 2019

CMOs and CDMOs expanded their services and facilities in the summer of 2019.

Partnering Up for Success

August 02, 2019

Pharmaceutical Technology Europe

To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.